B12 Injections
US$ 29.05
aod9604 wada prohibited status 2025 just added tirzepatide (mounjaro) to the 2026 Monitoring Program WADA's 2025 Prohibited List Now
Description
Native C-terminal fragment of human growth hormone (residues 176-191) activating lipolysis via beta-3 adrenergic receptor without GH receptor binding
The Takeaway An AOD-9604 weight loss peptide compounding pharmacy in Washington, DC offers access to this targeted fat-burning peptide in a safe, customized formulation
1 week (once daily): 14 swabs 2 weeks (once daily): 28 swabs 4 weeks (once daily): 56 swabs recommend 1 100-count box Protocol Overview Concise summary of the subcutaneous regimen
They are typically injected into a muscle
